You are here:
31 March 2021 / deal

Nordian Capital sells IGS GeboJagema to Smile Invest and minority investor Rabo Corporate Investment

Loyens & Loeff advised Nordian Capital on the sale of IGS GeboJagema, a market leading company in hightech medical moulds, to Smile Invest and minority investor Rabo Corporate Investments. The transaction is subject to the completion of customary regulatory approvals.

Nordian Capital on the sale of IGS GeboJagema


$800 million fundraise for MessageBird

US$800 million fundraise for MessageBird

This acquisition will intensify MessageBird’s focus on North America and tis competition with US rival Twilio Inc. read more
Couverture Financial Technology Law Review 2021

Luxembourg: A fintech-friendly jurisdiction

Luxembourg is a fintech-friendly jurisdiction, there are further steps to be taken to ensure a long-lasting implantation of innovative companies. read more
IFLR Awards 2021 Europe

IFLR Europe 2021 Award “Debt and Equity-Linked Deal of the Year”

Loyens & Loeff won for advising Novartis with the offering of EUR 1.85 billion 0.000% Sustainability-Linked Notes due 2028. read more